Skip to content

Axsome Therapeutics

US · AXSM #1533 by market cap Listed 2015
129.36 -6.32 -4.66%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions decreased by 11 in the most recent period (2026/Q3).
  • Total institutional ownership rose 1.3 percentage points.

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
91.63% +1.32pp
Institutions
604 -11
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund55.40%
Private Company15.93%
Hedge Fund11.85%
Public Company2.80%
VC/PE Fund2.31%
Government Pension Fund1.92%
Individual/Insider1.06%
Sovereign Wealth Fund0.98%
Insurance Company0.22%
Other7.54%

Top holders as of 2026-04-14

Antecip Capital, L.L.C. 13.96% · 7.34M sh
BlackRock 6.56% · 3.45M sh
Vanguard Capital Management, LLC 3.82% · 2.01M sh
Vanguard Portfolio Management, LLC 3.75% · 1.97M sh
Invesco Ltd. 3.03% · 1.59M sh
FMR 2.74% · 1.44M sh
Geode Capital Management, LLC 1.92% · 1.01M sh
UBS Asset Management 1.86% · 976.94K sh
Morgan Stanley 1.41% · 736.01K sh
State Street Global Advisors 1.57% · 823.33K sh
Franklin Resources 1.42% · 746.25K sh
Deep Track Capital, LP 1.34% · 700.00K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 21 buys · 29 sells

NameRoleStake
Antecip Capital, L.L.C. -- 13.96%
Mark Coleman Lead Independent Director 0.83%
Roger Jeffs Independent Director 0.11%
Nick Pizzie Chief Financial Officer 0.08%
Mark Saad Independent Director 0.02%
Herriot Tabuteau Chairperson & CEO 0.01%
Susan Mahony Independent Director 0.00%
Ari Maizel Chief Commercial Officer --
Mark Jacobson Chief Operating Officer --
Hunter Murdock General Counsel --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-02 Mark Jacobson Chief Operating Officer Derivative Exercise and Sale -10,000 $12.95–208.65
2026-08-05 Herriot Tabuteau Chairperson & CEO Derivative Exercise and Sale -49,664 $4.95–213.95
2026-08-05 Herriot Tabuteau Chairperson & CEO Intent to Sell (Form 144) -4,660 $210.13
2026-08-04 Herriot Tabuteau Chairperson & CEO Intent to Sell (Form 144) -45,004 $212.85
2026-06-30 Herriot Tabuteau Chairperson & CEO Derivative Exercise and Sale -49,666 $4.95–240.25
2026-06-10 Roger Jeffs Independent Director Automatic Disposition -572 $246.18–249.12
2026-06-10 Roger Jeffs Independent Director Intent to Sell (Form 144) -286 $249.12
2026-06-09 Roger Jeffs Independent Director Intent to Sell (Form 144) -286 $246.18
2026-06-09 Susan Mahony Independent Director Derivative Exercise and Sale -600 $237.21–246.18
2026-06-09 Susan Mahony Independent Director Intent to Sell (Form 144) -300 $246.18
2026-06-09 Mark Coleman Lead Independent Director Derivative Exercise and Sale -643 $249.00
2026-06-09 Mark Coleman Lead Independent Director Intent to Sell (Form 144) -643 $249.00
2026-06-08 Herriot Tabuteau Chairperson & CEO Derivative Exercise and Sale -49,670 $4.95–241.01
2026-06-08 Susan Mahony Independent Director Intent to Sell (Form 144) -300 $237.21
2026-06-08 Nick Pizzie Chief Financial Officer Derivative Exercise and Sale -33,000 $3.50–240.09
2026-06-07 Roger Jeffs Independent Director Derivative Exercise and Retained +1,429 --
2026-06-07 Mark Saad Independent Director Derivative Exercise and Retained +1,429 --
2026-06-07 Susan Mahony Independent Director Derivative Exercise and Retained +829 --
2026-06-07 Mark Coleman Lead Independent Director Derivative Exercise and Retained +786 --
2026-06-04 Roger Jeffs Independent Director Other Derivative Acquisition +1,721 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Axsome Therapeutics discussion 0 comments

Add a comment